Hyperphosphatemia results from a positive phosphorus balance in renal patients, which results in a compensatory secondary hyperparathyroidism and an increase in fibroblast growth factor-23 levels (FGF-23) [42]. This evidence concerns the gene FGF23 and secondary hyperparathyroidism.